Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare American International Group Inc (AIG) vs Pfizer Inc (PFE) Price & Performance

American International Group Inc
Pfizer Inc

Price performance

Price movement over the last 24 hours

Key statistics

American International Group Inc vs Pfizer Inc — how do they compare? American International Group Inc trades at $80.4 (market cap $42.98B), while Pfizer Inc trades at $24.24 (market cap $137.19B). The key difference: Pfizer Inc is far larger — about 3.2× American International Group Inc's market cap, and Pfizer Inc pays the higher dividend (7.15%). Which is the better fit depends on your goals.

AIGPFE
Market Cap
$42.98B$137.19B
Sector
FinancialsHealth
52-Week High
$86.59$28.56
52-Week Low
$71.89$23.29
Enterprise Value
$50.68B$187.84B
Dividend Yield
2.47%7.15%
Volume
29,869,932

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

American International Group Inc

AIG trades at $81.06, up 2.1% today, showing strong momentum with three consecutive quarterly earnings beats. The stock is supported by bullish technical signals and a consensus price target of $88.13. Recent executive appointments and the acquisition of Everest Colombia signal strategic growth initiatives. Revenue stabilized around $26.8B in 2025 with net income margin improving to 11.88%.

Outlook remains positive with earnings growth and expansion in Latin America offering upside potential. Risks include catastrophe exposure and competitive pressures. Analysts are predominantly neutral with 58.5% Hold ratings, suggesting cautious optimism amid solid fundamentals.

Pfizer Inc

Pfizer (PFE) trades at $23.72, down 2.47% on the day, with a bearish technical signal from moving averages but recent earnings beats. The stock has a P/E of 18.11 and net income margin of 11.83%, supported by strong cash flow from operations of $11.70B in 2025. Recent news highlights pipeline progress in obesity and oncology, with dividends of $0.43 paid semi-annually.

The outlook is mixed: analyst consensus is a 'Hold' with a $27.63 price target, implying potential upside, but risks include patent cliffs and competitive pressures. Revenue has declined from pandemic peaks, yet cost controls sustain profitability. Investors may find value if pipeline catalysts materialize, though near-term volatility persists.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About American International Group Inc

American International Group is one of the largest insurance and financial services firms in the world and has a global footprint. It operates through a wide range of subsidiaries that provide property, casualty, and life insurance. Its revenue is split roughly evenly between commercial and consumer lines.

Read more on AIG

About Pfizer Inc

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.

Read more on PFE